Dataset Viewer
Auto-converted to Parquet Duplicate
registry_id
stringlengths
17
17
year
int64
2.01k
2.02k
age
int64
0
95
age_group
stringclasses
8 values
sex
stringclasses
2 values
cancer_type
stringclasses
22 values
morphology
stringclasses
8 values
grade
stringclasses
5 values
basis_of_diagnosis
stringclasses
5 values
behavior
stringclasses
3 values
residence
stringclasses
3 values
treatment_status
stringclasses
8 values
vital_status
stringclasses
3 values
survival_months
float64
0
60
scenario
stringclasses
3 values
KE-NRB-2010-00001
2,010
45
45-54
Male
Oesophagus
Lymphoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
No treatment
Alive
34.1
high_burden
KE-NRB-2018-00002
2,018
24
15-24
Female
Other
Leukemia
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Peri-urban
Surgery only
Alive
25.8
high_burden
KE-NRB-2013-00003
2,013
42
35-44
Female
Other
Adenocarcinoma
Well differentiated (Grade I)
Imaging + clinical
Malignant
Urban
Surgery only
Lost to follow-up
60
high_burden
KE-NRB-2015-00004
2,015
71
65-74
Male
Colorectum
Sarcoma
Unknown
Microscopy (histology/cytology)
Benign/uncertain
Peri-urban
null
Dead
19
high_burden
KE-NRB-2012-00005
2,012
54
45-54
Female
Thyroid
Squamous cell carcinoma
Poorly differentiated (Grade III)
Clinical only
Malignant
Urban
Chemotherapy only
Alive
60
high_burden
KE-NRB-2014-00006
2,014
81
75+
Female
Breast
Sarcoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
38.3
high_burden
KE-NRB-2012-00007
2,012
17
15-24
Male
Bladder
Lymphoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
No treatment
Alive
0.8
high_burden
KE-NRB-2017-00008
2,017
52
45-54
Female
Other
Adenocarcinoma
Moderately differentiated (Grade II)
Imaging + clinical
Malignant
Peri-urban
Chemo + Radiotherapy
Alive
54.2
high_burden
KE-NRB-2016-00009
2,016
36
35-44
Male
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
3.6
high_burden
KE-NRB-2015-00010
2,015
52
45-54
Female
Corpus uteri
Lymphoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
11.1
high_burden
KE-NRB-2012-00011
2,012
67
65-74
Female
Other
Leukemia
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Dead
38.1
high_burden
KE-NRB-2016-00012
2,016
43
35-44
Female
Other
Squamous cell carcinoma
Moderately differentiated (Grade II)
Death certificate only
Malignant
Peri-urban
Surgery only
Dead
34.1
high_burden
KE-NRB-2013-00013
2,013
78
75+
Female
Breast
Squamous cell carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Dead
10.4
high_burden
KE-NRB-2009-00014
2,009
48
45-54
Male
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Alive
60
high_burden
KE-NRB-2017-00015
2,017
61
55-64
Female
Other
Squamous cell carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Palliative care only
Alive
22.4
high_burden
KE-NRB-2016-00016
2,016
67
65-74
Female
Cervix uteri
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
No treatment
Dead
24.1
high_burden
KE-NRB-2013-00017
2,013
47
45-54
Female
Other
Lymphoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
57
high_burden
KE-NRB-2017-00018
2,017
56
55-64
Male
Kaposi sarcoma
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Dead
6.6
high_burden
KE-NRB-2017-00019
2,017
44
35-44
Female
Cervix uteri
Non-keratinizing carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
16
high_burden
KE-NRB-2010-00020
2,010
41
35-44
Female
Other
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
13.8
high_burden
KE-NRB-2015-00021
2,015
29
25-34
Female
Cervix uteri
Adenocarcinoma
Well differentiated (Grade I)
Imaging + clinical
Malignant
Peri-urban
Chemotherapy only
Alive
60
high_burden
KE-NRB-2015-00022
2,015
35
35-44
Female
Breast
Non-keratinizing carcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Peri-urban
Surgery only
Alive
60
high_burden
KE-NRB-2013-00023
2,013
50
45-54
Female
Thyroid
Adenocarcinoma
Undifferentiated (Grade IV)
Other
Malignant
Urban
Surgery + Radiotherapy
Dead
9.2
high_burden
KE-NRB-2015-00024
2,015
57
55-64
Male
Oesophagus
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Alive
3.6
high_burden
KE-NRB-2016-00025
2,016
46
45-54
Male
Oesophagus
Squamous cell carcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Dead
15.8
high_burden
KE-NRB-2012-00026
2,012
56
55-64
Female
Ovary
Other specified
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Rural
Radiotherapy only
Alive
60
high_burden
KE-NRB-2012-00027
2,012
74
65-74
Female
Breast
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
60
high_burden
KE-NRB-2014-00028
2,014
35
35-44
Male
Bladder
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
60
high_burden
KE-NRB-2009-00029
2,009
39
35-44
Female
Other
Other specified
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Benign/uncertain
Urban
null
Dead
23.3
high_burden
KE-NRB-2014-00030
2,014
39
35-44
Female
Breast
Squamous cell carcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
38
high_burden
KE-NRB-2014-00031
2,014
35
35-44
Female
Other
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Imaging + clinical
Malignant
Urban
Surgery + Chemotherapy
Alive
14.5
high_burden
KE-NRB-2018-00032
2,018
90
75+
Male
Other
Adenocarcinoma
Moderately differentiated (Grade II)
Imaging + clinical
Malignant
Urban
Chemotherapy only
Dead
6
high_burden
KE-NRB-2014-00033
2,014
52
45-54
Female
Ovary
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Rural
Surgery only
Lost to follow-up
32.4
high_burden
KE-NRB-2012-00034
2,012
74
65-74
Female
Other
Sarcoma
Moderately differentiated (Grade II)
Clinical only
Malignant
Urban
Surgery + Chemotherapy
Alive
35.1
high_burden
KE-NRB-2015-00035
2,015
29
25-34
Male
Pancreas
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Dead
7
high_burden
KE-NRB-2016-00036
2,016
54
45-54
Female
Other
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
25.3
high_burden
KE-NRB-2011-00037
2,011
73
65-74
Female
Breast
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
No treatment
Alive
17.6
high_burden
KE-NRB-2017-00038
2,017
61
55-64
Female
Cervix uteri
Squamous cell carcinoma
Poorly differentiated (Grade III)
Clinical only
Malignant
Urban
Surgery only
Alive
19
high_burden
KE-NRB-2014-00039
2,014
67
65-74
Male
Colorectum
Lymphoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
No treatment
Lost to follow-up
47.9
high_burden
KE-NRB-2009-00040
2,009
2
0-14
Female
Breast
Lymphoma
Unknown
Clinical only
Malignant
Rural
Surgery + Radiotherapy
Alive
1.1
high_burden
KE-NRB-2011-00041
2,011
67
65-74
Male
Other
Unspecified
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Chemotherapy
Alive
46.8
high_burden
KE-NRB-2013-00042
2,013
23
15-24
Male
Other
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Clinical only
Malignant
Urban
Palliative care only
Alive
60
high_burden
KE-NRB-2018-00043
2,018
56
55-64
Male
Prostate
Squamous cell carcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
40
high_burden
KE-NRB-2017-00044
2,017
39
35-44
Male
Prostate
Lymphoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Alive
8.2
high_burden
KE-NRB-2018-00045
2,018
46
45-54
Female
Cervix uteri
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
4
high_burden
KE-NRB-2018-00046
2,018
32
25-34
Female
Breast
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
38.1
high_burden
KE-NRB-2016-00047
2,016
49
45-54
Female
Ovary
Other specified
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Peri-urban
Chemo + Radiotherapy
Alive
3.9
high_burden
KE-NRB-2009-00048
2,009
19
15-24
Male
Prostate
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
In situ
Urban
null
Dead
11
high_burden
KE-NRB-2013-00049
2,013
63
55-64
Female
Other
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
In situ
Urban
null
Dead
23.3
high_burden
KE-NRB-2018-00050
2,018
35
35-44
Female
Breast
Adenocarcinoma
Poorly differentiated (Grade III)
Imaging + clinical
Malignant
Urban
Radiotherapy only
Alive
12.4
high_burden
KE-NRB-2014-00051
2,014
66
65-74
Male
Non-Hodgkin lymphoma
Adenocarcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Dead
1
high_burden
KE-NRB-2014-00052
2,014
44
35-44
Female
Cervix uteri
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Dead
11.3
high_burden
KE-NRB-2016-00053
2,016
78
75+
Male
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Chemotherapy
Dead
1.7
high_burden
KE-NRB-2009-00054
2,009
60
55-64
Male
Stomach
Non-keratinizing carcinoma
Unknown
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Alive
43.1
high_burden
KE-NRB-2018-00055
2,018
39
35-44
Female
Thyroid
Non-keratinizing carcinoma
Well differentiated (Grade I)
Imaging + clinical
Malignant
Urban
Surgery only
Alive
60
high_burden
KE-NRB-2010-00056
2,010
63
55-64
Female
Breast
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Chemotherapy
Dead
21.9
high_burden
KE-NRB-2009-00057
2,009
36
35-44
Female
Cervix uteri
Other specified
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Alive
60
high_burden
KE-NRB-2018-00058
2,018
36
35-44
Female
Breast
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
In situ
Urban
null
Dead
9.2
high_burden
KE-NRB-2013-00059
2,013
33
25-34
Male
Other
Leukemia
Poorly differentiated (Grade III)
Imaging + clinical
Malignant
Urban
Surgery only
Lost to follow-up
5.7
high_burden
KE-NRB-2013-00060
2,013
50
45-54
Male
Lung
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Benign/uncertain
Urban
null
Alive
60
high_burden
KE-NRB-2018-00061
2,018
52
45-54
Female
Breast
Squamous cell carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Peri-urban
Chemo + Radiotherapy
Alive
60
high_burden
KE-NRB-2018-00062
2,018
28
25-34
Female
Breast
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
In situ
Urban
null
Lost to follow-up
24.9
high_burden
KE-NRB-2018-00063
2,018
64
55-64
Female
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
16.4
high_burden
KE-NRB-2015-00064
2,015
52
45-54
Male
Pancreas
Adenocarcinoma
Undifferentiated (Grade IV)
Imaging + clinical
Malignant
Urban
Chemo + Radiotherapy
Alive
16.5
high_burden
KE-NRB-2013-00065
2,013
18
15-24
Female
Cervix uteri
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Chemo + Radiotherapy
Alive
40
high_burden
KE-NRB-2016-00066
2,016
58
55-64
Female
Cervix uteri
Adenocarcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
24.5
high_burden
KE-NRB-2015-00067
2,015
64
55-64
Female
Breast
Other specified
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
In situ
Urban
null
Alive
58.1
high_burden
KE-NRB-2017-00068
2,017
34
25-34
Female
Thyroid
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Peri-urban
Radiotherapy only
Dead
27.4
high_burden
KE-NRB-2017-00069
2,017
92
75+
Male
Prostate
Non-keratinizing carcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Radiotherapy only
Lost to follow-up
60
high_burden
KE-NRB-2014-00070
2,014
78
75+
Female
Other
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Peri-urban
Surgery only
Alive
7
high_burden
KE-NRB-2016-00071
2,016
20
15-24
Male
Leukemia
Squamous cell carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
5.1
high_burden
KE-NRB-2014-00072
2,014
81
75+
Female
Ovary
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
36.5
high_burden
KE-NRB-2014-00073
2,014
77
75+
Female
Cervix uteri
Leukemia
Unknown
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
58.4
high_burden
KE-NRB-2016-00074
2,016
60
55-64
Female
Breast
Squamous cell carcinoma
Moderately differentiated (Grade II)
Clinical only
Malignant
Urban
Surgery + Radiotherapy
Alive
60
high_burden
KE-NRB-2012-00075
2,012
87
75+
Female
Cervix uteri
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
27.3
high_burden
KE-NRB-2013-00076
2,013
56
55-64
Female
Breast
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Peri-urban
Chemotherapy only
Dead
1.8
high_burden
KE-NRB-2010-00077
2,010
52
45-54
Female
Breast
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Dead
22.3
high_burden
KE-NRB-2015-00078
2,015
45
45-54
Female
Cervix uteri
Squamous cell carcinoma
Undifferentiated (Grade IV)
Death certificate only
Malignant
Urban
Surgery + Chemotherapy
Dead
11.1
high_burden
KE-NRB-2012-00079
2,012
54
45-54
Female
Cervix uteri
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Peri-urban
Surgery + Chemotherapy
Alive
60
high_burden
KE-NRB-2013-00080
2,013
16
15-24
Female
Other
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
10.6
high_burden
KE-NRB-2009-00081
2,009
64
55-64
Male
Colorectum
Adenocarcinoma
Undifferentiated (Grade IV)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
23
high_burden
KE-NRB-2010-00082
2,010
61
55-64
Female
Other
Non-keratinizing carcinoma
Well differentiated (Grade I)
Clinical only
Malignant
Rural
Chemo + Radiotherapy
Alive
60
high_burden
KE-NRB-2009-00083
2,009
55
55-64
Male
Colorectum
Sarcoma
Moderately differentiated (Grade II)
Clinical only
Malignant
Urban
Surgery only
Dead
15.9
high_burden
KE-NRB-2017-00084
2,017
43
35-44
Female
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Imaging + clinical
Malignant
Urban
Surgery + Chemotherapy
Alive
36.5
high_burden
KE-NRB-2013-00085
2,013
86
75+
Male
Colorectum
Leukemia
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Dead
19.3
high_burden
KE-NRB-2015-00086
2,015
12
0-14
Male
Colorectum
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Chemotherapy only
Alive
1.2
high_burden
KE-NRB-2016-00087
2,016
44
35-44
Male
Other
Adenocarcinoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Peri-urban
Chemotherapy only
Alive
55.9
high_burden
KE-NRB-2016-00088
2,016
58
55-64
Male
Other
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Peri-urban
Surgery + Chemotherapy
Alive
11.2
high_burden
KE-NRB-2017-00089
2,017
63
55-64
Female
Corpus uteri
Lymphoma
Undifferentiated (Grade IV)
Imaging + clinical
Malignant
Urban
No treatment
Lost to follow-up
60
high_burden
KE-NRB-2013-00090
2,013
36
35-44
Female
Other
Squamous cell carcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Peri-urban
Radiotherapy only
Alive
60
high_burden
KE-NRB-2012-00091
2,012
40
35-44
Female
Other
Adenocarcinoma
Unknown
Other
Malignant
Urban
Radiotherapy only
Alive
60
high_burden
KE-NRB-2011-00092
2,011
31
25-34
Female
Cervix uteri
Sarcoma
Moderately differentiated (Grade II)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Chemotherapy
Alive
38.1
high_burden
KE-NRB-2018-00093
2,018
60
55-64
Male
Prostate
Squamous cell carcinoma
Unknown
Microscopy (histology/cytology)
Malignant
Peri-urban
Chemotherapy only
Dead
6.5
high_burden
KE-NRB-2014-00094
2,014
41
35-44
Female
Other
Adenocarcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Chemotherapy
Alive
0.1
high_burden
KE-NRB-2010-00095
2,010
52
45-54
Male
Non-Hodgkin lymphoma
Squamous cell carcinoma
Poorly differentiated (Grade III)
Imaging + clinical
Malignant
Urban
Surgery only
Alive
60
high_burden
KE-NRB-2016-00096
2,016
26
25-34
Female
Cervix uteri
Non-keratinizing carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery only
Alive
60
high_burden
KE-NRB-2015-00097
2,015
67
65-74
Male
Leukemia
Squamous cell carcinoma
Poorly differentiated (Grade III)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Radiotherapy
Alive
60
high_burden
KE-NRB-2010-00098
2,010
74
65-74
Female
Other
Squamous cell carcinoma
Poorly differentiated (Grade III)
Death certificate only
In situ
Peri-urban
null
Dead
39.3
high_burden
KE-NRB-2015-00099
2,015
61
55-64
Female
Other
Adenocarcinoma
Unknown
Clinical only
Malignant
Urban
Chemotherapy only
Alive
25.5
high_burden
KE-NRB-2014-00100
2,014
63
55-64
Female
Other
Adenocarcinoma
Well differentiated (Grade I)
Microscopy (histology/cytology)
Malignant
Urban
Surgery + Chemotherapy
Dead
60
high_burden
End of preview. Expand in Data Studio

Kenya Cancer Registry - Nairobi | Africa (Electric Sheep Africa metadata inventory)

Size category: 10K<n<100K - Formats: csv - Sector: health - Engineered by Electric Sheep Africa

size sector downloads license

TL;DR

This dataset is part of the Electric Sheep Africa catalog on Hugging Face. It is indexed for African data discovery with standardized metadata, loading guidance, provenance notes, and analyst-oriented context.

What This Dataset Covers

Health datasets help researchers examine disease burden, service delivery, risk factors, outcomes, and public-health program performance.

Dataset context from the existing Hugging Face card: ⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference. Kenya Cancer Registry - Nairobi Abstract This synthetic dataset represents population-based cancer registry data for nairobi county and is designed to address the significant data gap in cancer research for sub-Saharan Africa. The dataset contains 4,000-6,000 per scenario records per scenario with key epidemiological… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya.

Dataset Profile

Field Value
Hugging Face repo electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya
Sector health
Topic tags cancer, oncology, synthetic, healthcare, sub-saharan-africa, kenya
Modalities tabular, text
Formats csv
Size category 10K<n<100K
Countries Kenya
ISO3 coverage KEN
Last modified on HF 2026-04-14 22:47:28+00:00
Inventory snapshot 2026-07-16T16:00:34Z

How To Read This Dataset

  • Start from the repository files and the dataset viewer when available.
  • Treat the README context as a fast orientation layer; confirm variable definitions and units in the data files before modeling.
  • Use explicit country columns when present. When geography is only implied by the title or source metadata, document that assumption in downstream analysis.
  • Preserve missing values until you have a defensible imputation rule.

Usage

from datasets import load_dataset

ds = load_dataset("electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya")
print(ds)

split_name = next(iter(ds))
table = ds[split_name]
print(table.features)
print(table[:3])

Convert To Pandas When Tabular

from datasets import Dataset

first_split = ds[next(iter(ds))]
if isinstance(first_split, Dataset):
    df = first_split.to_pandas()
    print(df.head())

Data Quality Notes

  • This card was standardized from the Electric Sheep Africa Hugging Face metadata inventory.
  • Exact schema, row counts, and source files should be inspected in the repository data files.
  • Metadata gaps from the inventory: upstream_publisher.
  • Do not infer policy meaning from labels alone; confirm definitions, units, and methods in the source material.

Source And Provenance

Suggested Analyses

  • Inspect schema and missingness before modeling.
  • Profile variables by geography, time, and subgroup columns where present.
  • Join with other Electric Sheep Africa datasets using explicit country, year, and indicator fields when available.
  • Build reproducible notebooks that cite both the original source context and the Electric Sheep Africa Hugging Face repo.

Citation

@misc{electric_sheep_africa_africa_synth_cancer_kenya_cancer_nairobi_kenya_2026,
  title        = {Kenya Cancer Registry - Nairobi | Africa (Electric Sheep Africa metadata inventory)},
  author       = {Public dataset metadata},
  year         = {2026},
  url          = {https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya},
  publisher    = {Hugging Face Datasets, engineered by Electric Sheep Africa},
  howpublished = {\url{https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya}}
}

License

Released under CC BY 4.0.

Original source rights remain with the original publisher or data provider. Electric Sheep Africa engineering standardizes discovery metadata, documentation, and usage guidance for analysis on Hugging Face.

About Electric Sheep Africa

Electric Sheep Africa publishes ML-ready African public datasets on Hugging Face.


Provenance: metadata-backed README standardized 2026-08-12 by the Electric Sheep Africa README system. Inventory source: catalog/esa_metadata_inventory/master_metadata.jsonl.

Downloads last month
40

Collection including electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya